Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02749214 · ClinicalTrials.gov registry record

Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes

A clinical trial of Parkinson's Disease, sponsored by Emory University.

Completed
Registry status
100
Enrollment target
1
Study location

NCT02749214 is a study of Parkinson's Disease that has completed, run by Emory University. The registered enrollment target is 100 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02749214, a study of Parkinson's Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the potential for a Parkinson's Disease (PD) -specific breath signature as a non-invasive screening tool for identifying PD patients with inflammation, tracking the progression of disease, and responsiveness to various therapeutic interventions, in particular anti-inflammatory or immunomodulatory therapies. Neurological disorders include any disorder involving the brain or the nervous system, for example memory disorders, stroke, movement disorders and many other conditions. The study will lay the foundation for future studies in which breath fingerprinting could be used as a screening technique. Investigators will also be looking at how the breath fingerprint correlates with inflammatory proteins in the blood.

Conditions Studied

Parkinson's Disease

Interventions

  • OTHER Blood Sample Collection
  • OTHER Breath Sample Collection

Study Locations (1)

Georgia

  • The Emory Clinic Executive Park - Atlanta

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2016-02
Est. Completion 2019-05

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02749214

The ClinicalTrials.gov registry entry for NCT02749214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (84% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which Blood Sample Collection is the first listed.

NCT02749214 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT02749214 about?

NCT02749214 is a clinical study titled "Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes". The purpose of this study is to determine the potential for a Parkinson's Disease (PD) -specific breath signature as a non-invasive screening tool for identifying PD patients with inflammation, tracking the progression of disease, and responsiveness to various therapeutic interventions, in particula...

What is the current status of trial NCT02749214?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2016-02. Estimated completion is 2019-05.

What conditions does trial NCT02749214 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT02749214?

The interventions under investigation include: Blood Sample Collection (OTHER), Breath Sample Collection (OTHER).

Who is sponsoring clinical trial NCT02749214?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02749214 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.